HIV/AIDS Clinical Trials

Find HIV/AIDS Clinical Trials Near You

Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The overall hypothesis is that stabilizing transgender women financially while providing them tailored counselling will increase their odds of them linking to substance use services, PrEP services if they do not have HIV, and transgender women who are living with HIV will be more adherent to their ART treatment.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:

• Aged ≥18 years

• Male at birth

• Identify as a woman/transgender woman

• Should not be consistently using PrEP (less than four doses per week)

• Should not have any known allergy or adverse reaction to PrEP or the active drug tenofovir in ART. One of the goals of the study is to move more people into a PrEP program

• Be able to speak and understand spoken English and/or Spanish (including persons who cannot read or write)

• Have a smart phone that can take pictures

Locations
United States
Florida
University of Central Florida
RECRUITING
Orlando
Contact Information
Primary
Elena Cyrus, PhD
elena.cyrus@ucf.edu
4072661507
Backup
Amoy Fraser, PhD, CCRP, PMP
amoy.fraser@ucf.edu
4072668742
Time Frame
Start Date: 2023-07-11
Estimated Completion Date: 2027-06
Participants
Target number of participants: 110
Treatments
Experimental: ENTRUST
The proposed intervention 'ENTRUST' will address structural disparities transgender women encounter by providing skills to aid with economic navigation while simultaneously strengthening and improving social cohesion to increase the odds of them linking to care that is available to them.
Active_comparator: Control
Comparison control group.
Related Therapeutic Areas
Sponsors
Collaborators: Sunserve, 26Health, Survivor's Pathway, National Institute of Drug Abuse
Leads: University of Central Florida

This content was sourced from clinicaltrials.gov